Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Many people with alopecia experience high levels of social anxiety, anxiety, and depression, and while wigs can boost confidence, they may also cause anxiety.

Hair loss in women is linked to higher depression symptoms.

Finasteride may increase depression by reducing brain cell growth.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

Women with polycystic ovarian syndrome often experience depression and anxiety.

Finasteride may increase the risk of depression, anxiety, and suicidal thoughts.

Alopecia areata patients have worse quality of life, anxiety, and depression than vitiligo patients.

Low levels of BDNF and vitamin D are linked to higher depression in alopecia areata and vitiligo patients.

Patients with Alopecia Areata often have higher anxiety and depression.

Hair loss in South Saudi Arabia adults often harms quality of life and leads to depression.

Depression may be linked to changes in body electrolytes and muscle inactivity, similar to effects of weightlessness.

Women with Polycystic Ovary Syndrome (PCOS) often have higher levels of anxiety and depression, especially if they live in rural areas, have less education, don't have children, are over 30, or are obese.

Women with PCOS are more likely to have depression and anxiety.

No proven link between isotretinoin and depression.

People with psoriasis and depression have lower BDNF levels, which could help measure depression in those with psoriasis.

Women with PCOS and higher BMI, especially those with morbid obesity, are at greater risk for depression.

Finasteride may increase the risk of suicidality and depression, especially in younger people.

Children with alopecia areata often face neglectful parenting, leading to higher anxiety and depression.

Finasteride does not consistently cause depression.

Finasteride for hair loss often causes depression, with risks outweighing benefits.

Finasteride may lower depression risk in younger men with hair loss but increase it in older men with prostate issues.

Finasteride may cause depression and suicidal thoughts, especially in young men.

5-alpha reductase inhibitors slightly increase depression risk, but the risk varies based on the control group used.

Gender-diverse individuals face more depression and anxiety, possibly due to unique stress profiles.

Finasteride and dutasteride may increase the risk of depression and suicidality, so patients should be monitored closely.

Depression and anxiety are common in SLE patients and worsen disease symptoms.

Finasteride may increase depression and suicide risks, needing better safety checks and informed consent.

Hair loss is linked to higher depression, especially in certain groups.

Gender-diverse people face more depression and anxiety, partly due to stress and lower cortisol levels.

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.